Another mitochondrial disease patient with different compound heterozygous NSUN3 mutations presented at the age of four months with muscle weakness, hypotonia, lactic acidosis, global developmental delay, and seizures29. This evidence concerns the gene NSUN3 and inborn mitochondrial metabolism disorder.